A new European initiative aims to accelerate earlier diagnosis and improve access to treatment for people living with ...

Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to accelerate ...

Cardiovascular diseases remain the leading cause of death in Europe, claiming 1.7 million lives annually, the head of the ...

Mosquito-borne diseases such as West Nile virus (WNV), chikungunya, and dengue are spreading more widely and for longer durations across Europe, with health authorities warning that changing climate ...

Cardiovascular disease remains a major concern in cities, with poor outcomes and high societal cost often driven by unequal access to healthcare.  A pan-European consortium of 34 international ...

A network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease threats. The Pan-European Network for Disease Control ...

Cardiovascular diseases (CVDs) are the leading cause of death and disability across the European Union, accounting for about 1.7 million deaths annually and affecting 62 million people, according to ...

Chronic liver disease and pancreatitis were among the digestive diseases with high increases in incidence and mortality since 2000. Digestive diseases affect more than 300 million people in Europe and ...

Today, 15 May 2023, the European Society of Endocrinology (ESE), the European Hormone and Metabolism Foundation (ESE Foundation) and other partners are marking the second European Hormone Day.